Glen Donovan Net Worth

The estimated Net Worth of Glen Donovan is at least $1.01 Million dollars as of 3 March 2021. Mr. Donovan owns over 16,347 units of PPD Inc stock worth over $914,726 and over the last 5 years he sold PPD stock worth over $98,475. In addition, he makes $0 as Chief Accounting Officer at PPD Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Donovan PPD stock SEC Form 4 insiders trading

Glen has made over 3 trades of the PPD Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 16,347 units of PPD stock worth $173,115 on 3 March 2021.

The largest trade he's ever made was exercising 16,347 units of PPD Inc stock on 3 March 2021 worth over $173,115. On average, Glen trades about 2,811 units every 80 days since 2019. As of 3 March 2021 he still owns at least 19,347 units of PPD Inc stock.

You can see the complete history of Mr. Donovan stock trades at the bottom of the page.

Glen Donovan biography

Glen Donovan serves as Chief Accounting Officer of the Company. Prior to joining the Company, Mr. Donovan served in various roles at Deloitte & Touche, a multinational professional services network, from November 1996 to May 2015, including as audit and assurance partner from September 2011 to May 2015.

How old is Glen Donovan?

Glen Donovan is 46, he's been the Chief Accounting Officer of PPD Inc since 2015. There are 13 older and 5 younger executives at PPD Inc. The oldest executive at PPD Inc is Jeffrey Kindler, 64, who is the Independent Director.

What's Glen Donovan's mailing address?

Glen's mailing address filed with the SEC is C/O PPD, INC., 929 NORTH FRONT STREET, WILMINGTON, NC, 28401.

Insiders trading at PPD Inc

Over the last 21 years, insiders at PPD Inc have traded over $14,532,346,241 worth of PPD Inc stock and bought 130,455 units worth $3,520,800 . The most active insiders traders include Corporate Investors Viii, L..., Corporate Investors Vii, Lt..., and Group Management L.L.C.Carl.... On average, PPD Inc executives and independent directors trade stock every 53 days with the average trade being worth of $124,899,671. The most recent stock trade was executed by Corporate Investors Viii, L... on 8 December 2021, trading 132,841,266 units of PPD stock currently worth $6,309,960,135.

What does PPD Inc do?

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Company's customers include pharmaceutical, biotechnology, medical device, academic and government organization s. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.

Complete history of Mr. Donovan stock trades at PPD Inc

PPD Inc executives and stock owners

PPD Inc executives and other stock owners filed with the SEC include:

• David Simmons,
  Chairman of the Board, Chief Executive Officer
• William Sharbaugh,
  Chief Operating Officer
• Christopher Scully,
  Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary
• Anshul Thakral,
  Executive Vice President, Chief Commercial Officer
• B. Judd Hartman,
  Executive Vice President, Chief Administrative Officer, General Counsel
• Jeffrey Kindler,
  Independent Director
• Colin Hill,
  Independent Director
• Maria Hilado,
  Independent Director
• Tracy Krumme,
  Vice President, Head of Investor Relations
• Stephen Wise,
  Independent Director
• Allen Thorpe,
  Independent Director
• P. Hunter Philbrick,
  Independent Director
• Stephen Ensley,
  Independent Director
• Joe Bress,
  Independent Director
• Glen Donovan,
  Chief Accounting Officer
• Roger Smith,
  Senior Vice President and General Manager of AES
• Karen Kaucic,
  Executive Vice President and President of Evidera, Chief Medical Officer
• David Johnston,
  Executive Vice President - Global Clinical Development
• Christopher Fikry,
  Executive Vice President - Global Laboratory Services
• Ronald Garrow,
  Chief Human Resource Officer, Executive Vice President
• Group Inc.Carlyle Group Man...,
  
• Group Management L.L.C.Carl...,
  
• Jill Pellegrino,
  SVP & General Manager of AES
• Peter Grunebaum,
  Director
• Cecil Mark Brown,
  Sr. VP & CEO
• Charlie Stephen Williamson,
  Chief Financial Officer
• Kathleen Susan Pinson,
  Vice President
• Randy Harp,
  Chief Operating Officer
• Harland Cecil Stonecipher,
  Founder, Chairman of the Board
• Martin H Belsky,
  Director
• John W Hail,
  Director
• Steven Riley Hague,
  Director
• Paid Legal Services Inc Pre,
  Director
• Judd Hartman,
  See Remarks
• Thomas W Smith,
  10% owner
• Corporate Investors Viii, L...,
  
• Julia James,
  EVP, General Counsel,Secretary